TY - JOUR
T1 - Binding thermodynamics of (E)-2-((2-hydroxybenzylidene)amino)-5-methylbenzonitrile and (E)-2-((2-hydroxybenzylidene)amino)-5-methylbenzonitrile cobalt(ii) with HSA
T2 - an experimental and molecular dynamic study
AU - Sookai, Sheldon
AU - Waziri, Ibrahim
AU - Muller, Alfred J.
AU - Nowakowska, Monika
N1 - Publisher Copyright:
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique, 2026
PY - 2026/1/5
Y1 - 2026/1/5
N2 - The interaction of small-molecule ligands with human serum albumin (HSA) critically influences drug bioavailability and pharmacokinetics. This study examines the binding characteristics of the free ligand HL and its cobalt(ii) complex, CoL, using spectroscopic techniques, molecular docking, and molecular dynamics (MD) simulations. Fluorescence quenching assays confirm a dose-dependent interaction via a dynamic quenching mechanism, with HL exhibiting a 1.8-fold higher binding affinity at 310 K (log Ka = 5.13) than CoL (log Ka = 4.90), indicating reduced protein interaction upon metal complexation. Thermodynamic analyses reveal ΔH and ΔS values for HL and CoL to be 16.34, 10.36 kJ mol−1 and 0.15, 0.13 J K−1 mol−1, respectively, indicating an entropy-driven binding process, with HL demonstrating greater entropic contribution. Circular dichroism spectroscopy (UV-CD) shows minimal secondary structure perturbation, though CoL induces a slight reduction in α-helicity. Near-UV CD shifts and in silico docking confirm preferential binding at Sudlow's site I, near Trp-214, supporting fluorescence data. Furthermore, site displacement assays suggest possible multi-site binding for both CoL and HL. Experimental data was well supported by MD simulations over a 100 ns trajectory. These findings suggest HL's stronger HSA affinity could influence its bioavailability, whereas CoL exhibits reduced binding due to steric and electronic effects of metal coordination. This study enhances understanding of protein–ligand interactions, informing rational drug design strategies for albumin-bound therapeutics.
AB - The interaction of small-molecule ligands with human serum albumin (HSA) critically influences drug bioavailability and pharmacokinetics. This study examines the binding characteristics of the free ligand HL and its cobalt(ii) complex, CoL, using spectroscopic techniques, molecular docking, and molecular dynamics (MD) simulations. Fluorescence quenching assays confirm a dose-dependent interaction via a dynamic quenching mechanism, with HL exhibiting a 1.8-fold higher binding affinity at 310 K (log Ka = 5.13) than CoL (log Ka = 4.90), indicating reduced protein interaction upon metal complexation. Thermodynamic analyses reveal ΔH and ΔS values for HL and CoL to be 16.34, 10.36 kJ mol−1 and 0.15, 0.13 J K−1 mol−1, respectively, indicating an entropy-driven binding process, with HL demonstrating greater entropic contribution. Circular dichroism spectroscopy (UV-CD) shows minimal secondary structure perturbation, though CoL induces a slight reduction in α-helicity. Near-UV CD shifts and in silico docking confirm preferential binding at Sudlow's site I, near Trp-214, supporting fluorescence data. Furthermore, site displacement assays suggest possible multi-site binding for both CoL and HL. Experimental data was well supported by MD simulations over a 100 ns trajectory. These findings suggest HL's stronger HSA affinity could influence its bioavailability, whereas CoL exhibits reduced binding due to steric and electronic effects of metal coordination. This study enhances understanding of protein–ligand interactions, informing rational drug design strategies for albumin-bound therapeutics.
UR - https://www.scopus.com/pages/publications/105024674717
U2 - 10.1039/d5nj03624k
DO - 10.1039/d5nj03624k
M3 - Article
AN - SCOPUS:105024674717
SN - 1144-0546
VL - 50
SP - 471
EP - 486
JO - New Journal of Chemistry
JF - New Journal of Chemistry
IS - 1
ER -